Effects of Erythrocarpine E on Human Oral Cancer Cells
Author Information
Author(s): Nagoor Noor Hasima, Shah Jehan Muttiah Norliza, Soon Lim Chong, In Lionel L. A., Mohammad Khalit, Awang Khalijah
Primary Institution: University Malaya
Hypothesis
The study aims to determine the cytotoxic and apoptotic effects of erythrocarpine E on human oral squamous cell carcinoma.
Conclusion
Erythrocarpine E induces cytotoxicity and apoptosis in HSC-4 oral cancer cells, suggesting its potential as a cancer chemopreventive agent.
Supporting Evidence
- CEB4 treated HSC-4 cells showed a cytotoxic effect and inhibited cell proliferation.
- CEB4 induced apoptosis mediated cell death through the p53 signaling pathway.
- CEB4 had minimal cytotoxic effects on normal cells, maintaining cell viability above 80%.
- CEB4 treatment resulted in increased levels of pro-apoptotic protein Bax and decreased levels of anti-apoptotic protein Bcl-2.
Takeaway
This study found that a natural compound called erythrocarpine E can kill cancer cells in the mouth and might help in treating oral cancer.
Methodology
The study used MTT assays, annexin V-FITC staining, DNA fragmentation assays, and Western blotting to assess cytotoxicity and apoptosis.
Limitations
The study primarily focuses on in vitro results, and in vivo effects need further investigation.
Statistical Information
P-Value
4.0±1.9 µM
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website